| Literature DB >> 36253795 |
John P O'Connor1, Paige Holden2, Joel J Gagnier3.
Abstract
BACKGROUND: Total hip arthroplasties (THA) are cost-effective interventions for patients with osteoarthritis refractory to physical therapy or medical management. Most individuals report positive surgical outcomes with reduction in pain and improved joint function. Multiple recent studies demonstrated the influence of patient mental health on surgical success. We sought to determine the relationship between patient preoperative psychological factors and postoperative THA outcomes, specifically pain and function.Entities:
Keywords: Anxiety; Depression; Mental health; Operative outcomes; Systematic review; Total hip arthroplasty
Mesh:
Year: 2022 PMID: 36253795 PMCID: PMC9575292 DOI: 10.1186/s13018-022-03355-3
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.677
Fig. 1Flow diagram of study selection process
Risk of bias assessment for observational studies
| Was the outcome absent at the start of the study? | Are all members of the cohort equally capable of developing the outcome? | Was the outcome measurement performed in the same manner with similar intensity in the groups being compared? | Were the groups similar at baseline? | Did the authors perform analyses adjusting for known confounders? | Were all the withdrawals and dropsout described and accounted for? | Did the authors describe other possible sources of bias or confounders? | |
|---|---|---|---|---|---|---|---|
| Badura-Brzoza [ | Yes | Yes | Yes | Yes | No | No | No |
| Benditz [ | Yes | Yes | Yes | ? | No | Yes | Yes |
| Brembo [ | Yes | Yes | Yes | ? | Yes | Yes | Yes |
| Duivenvoorden [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Etcheson [ | Yes | Yes | Yes | Yes | Yes | No | Yes |
| Galea [ | Yes | Yes | Yes | No | Yes | Yes | Yes |
| Hassett [ | Yes | Yes | Yes | Yes | Yes | No | Yes |
| Hossain [ | Yes | Yes | Yes | No | Yes | No | Yes |
| Jaiswal [ | Yes | Yes | Yes | No | Yes | Yes | No |
| Lindner [ | Yes | Yes | Yes | ? | No | Yes | Yes |
| Mercurio [ | Yes | Yes | Yes | ? | No | Yes | Yes |
| Negrini [ | Yes | Yes | No | ? | No | No | Yes |
| Pinto [ | Yes | Yes | Yes | Yes | No | No | Yes |
| Quintana [ | Yes | Yes | Yes | No | Yes | Yes | Yes |
| Rasouli [ | Yes | Yes | Yes | Yes | Yes | No | Yes |
| Riediger [ | Yes | Yes | Yes | No | No | Yes | No |
| Rolfson [ | Yes | Yes | Yes | Yes | Yes | No | No |
| Salmon [ | Yes | Yes | Yes | Yes | No | Yes | No |
| Singh [ | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Tarakji [ | Yes | Yes | Yes | No | No | No | Yes |
| Trinh [ | Yes | Yes | Yes | No | Yes | Yes | Yes |
Yes this criterion was fulfilled, No this criterion was not fulfilled; ?, it was not possible to determine whether or not the criterion was fulfilled due to underreporting or unclear language
Study conclusions
| Risk of bias score | Author, year | n | Follow-up duration | Psychological variable(s) | Main conclusion(s) |
|---|---|---|---|---|---|
| < 5 | Riediger [ | 79 | 2 months | Depression, somatization | ↑ Depression/somatization associated with ↑ pain |
| Tarakji [ | 44 | 3,12 months | Depression | ↑ Depression associated with ↑ pain | |
| 5–7 | Brembo [ | 223 | 3 months | Self-efficacy | ↓ Self-efficacy associated with ↑ pain |
| Duivenvoorden [ | 140 | 3,12 months | Depression/anxiety | ↑ Anxiety/depression associated with ↑ pain | |
| Etcheson [ | 93 | 48 h | Depression | ↑ Depression has no significant impact on pain | |
| Hassett [ | 862 | 3,6 months | Depression/anxiety | ↑ Anxiety/depression associated with ↑ pain | |
| Lindner [ | 44 | 6,12 weeks | Depression/anxiety | ↑ Anxiety associated with ↑ pain; ↑ Depression has no significant impact on pain | |
| Mercurio [ | 40 | 12 months | Depression/anxiety | ↑ Anxiety/depression ↑ pain | |
| Pinto [ | 64 | 48 h | Depression/anxiety, optimism | ↑ Anxiety/depression have no significant impact on pain; ↑ Optimism associated with ↓ pain | |
| Quintana [ | 788 | 6 months, 2 years | Mental health | ↓ Mental health associated with ↑ pain | |
| Rolfson [ | 6,158 | 1 year | Depression/anxiety | ↑ Anxiety/depression associated with ↑ pain | |
| Singh [ | 441 | 2 years | Pessimism | ↑ Pessimism has no significant impact on pain | |
| < 5 | Badura-Brzoza [ | 184 | 6 months | Depression/anxiety | ↑ Anxiety/depression have no significant impact on function |
| Negrini [ | 40 | 3,12 days | Depression/anxiety | ↑ Anxiety/depression have no significant impact on function | |
| Riediger [ | 79 | 2 months | Depression, somatization | ↑ Depression/somatization associated with ↓ function | |
| Tarakji [ | 44 | 3,12 months | Depression | ↑ Depression associated with ↓ function | |
| 5–7 | Benditz [ | 50 | 1,5 weeks | Depression/anxiety | ↑ Anxiety/depression associated with ↓ function |
| Brembo [ | 223 | 3 months | Self-efficacy | ↓ Self-efficacy associated with ↓ function | |
| Duivenvoorden [ | 140 | 3,12 months | Depression/anxiety | ↑ Anxiety/depression associated with ↓ function | |
| Galea [ | 627 | 3 months, 1,7 years | Depression/anxiety | ↑ Anxiety/depression associated with ↓ function | |
| Hossain [ | 762 | 1,5 years | Distress | ↑ Distress associated with ↓ function | |
| Lindner [ | 44 | 6,12 weeks | Depression/anxiety | ↑ Anxiety associated with ↓ function; ↑ Depression has no significant impact on function | |
| Quintana [ | 788 | 6 months, 2 years | Mental health | ↓ Mental health associated with ↓ function | |
| Salmon [ | 102 | 1,6 months | Depression/anxiety | ↑ Anxiety associated with ↓ function | |
| Singh [ | 441 | 2 years | Pessimism | ↑ Pessimism associated with ↓ function | |
| Trinh [ | 48 | 1 year | Depression | ↑ Depression associated with ↓ function | |
| 5–7 | Jaiswal [ | 677 | 1 year | Mental health | ↓ Mental health associated with ↓ function and ↑ pain |
| 5–7 | Rasouli [ | 964 | NR | Complications | ↑ Anxiety/depression associated with ↑ complications |
NR Not recorded; ↑ increased; ↓ decreased
GRADE function
| Certainty assessment | No. of patients | ||||||
|---|---|---|---|---|---|---|---|
| Follow-up | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Quality | |
| 0–1 week | None | ||||||
| 1–12 weeks | 4 observational studies | None | Not serious | Not serious | Not serious | Low | 264 |
| 12 weeks–6 months | 3 observational studies | None | Not serious | Not serious | Not serious | Low | 907 |
| 6 months–2 years | 1 observational study | None | Not serious | Not serious | Not serious | Low | 310 |
| Over 2 years | None | ||||||
| 0–1 week | None | ||||||
| 1–12 weeks | 3 observational studies | None | Not serious | Not serious | Not serious | Low | 1033 |
| 12 weeks–6 months | 1 observational study | None | Not serious | Not serious | Not serious | Low | 184 |
| 6 months–2 years | 2 observational studies | None | Not serious | Not serious | Not serious | Low | 844 |
| Over 2 years | 1 observational study | None | Not serious | Not serious | Not serious | Low | 627 |
| 0–1 week | 1 observational study | None | Not serious | Not serious | Not serious | Low | 50 |
| 1–12 weeks | 2 observational studies | None | Not serious | Not serious | Not serious | Low | 960 |
| 12 weeks–6 months | None | ||||||
| 6 months–2 years | 1 observational study | None | Not serious | Not serious | Not serious | Low | 800 |
| Over 2 years | 1 observational study | None | Not serious | Not serious | Not serious | Low | 627 |
| 0–1 week | None | ||||||
| 1–12 weeks | None | ||||||
| 12 weeks–6 months | None | ||||||
| 6 months–2 years | 1 observational study | None | Not serious | Not serious | Not serious | Low | 140 |
| Over 2 years | none | ||||||
| 0–1 week | 1 observational study | Serious | Not serious | Serious | Serious | Very low | 40 |
| 1–12 weeks | 1 observational study | Serious | Not serious | Serious | Serious | Very low | 40 |
| 12 weeks–6 months | None | ||||||
| 6 months–2 years | None | ||||||
| Over 2 years | None | ||||||
| 0–1 week | None | ||||||
| 1–12 weeks | None | ||||||
| 12 weeks–6 months | None | ||||||
| 6 months–2 years | 1 observational study | None | Not serious | Not serious | Not serious | Low | 908 |
| Over 2 years | 1 observational study | None | Not serious | Not serious | Not serious | Low | 762 |
| 0–1 week | None | ||||||
| 1–12 weeks | None | ||||||
| 12 weeks–6 months | None | ||||||
| 6 months–2 years | 1 observational study | None | Not serious | Serious | Not serious | Low | 48 |
| Over 2 years | None | ||||||
| 0–1 week | None | ||||||
| 1–12 weeks | None | ||||||
| 12 weeks–6 months | None | ||||||
| 6 months–2 years | 1 observational study | None | Not serious | Serious | Not serious | Very losw | 441 |
| Over 2 years | None | ||||||
WOMAC Western Ontario and McMaster University Osteoarthritis Index, Pain pain subscale, PF Physical functioning subscale, SF-36 PCS Short-form health survey physical component score, HHS Harris hip score, HOOS Hip dysfunction and osteoarthritis outcome score, OHS Oxford hip score, PROMIS-10 Patient reported outcomes measurement information system-10
GRADE pain
| Certainty assessment | No. of patients | ||||||
|---|---|---|---|---|---|---|---|
| Follow-up | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Quality | |
| 0–1 week | None | ||||||
| 1–12 weeks | 3 observational studies | None | Not serious | Not serious | Not serious | Low | 167 |
| 12 weeks–6 months | 2 observational studies | None | Not serious | Not serious | Not serious | Low | 813 |
| 6 months–2 years | 2 observational studies | None | Not serious | Serious | Not serious | Very low | 350 |
| Over 2 years | None | ||||||
| 0–1 week | 1 observational study | None | Not serious | Not serious | Not serious | Low | 93 |
| 1–12 weeks | None | ||||||
| 12 weeks–6 months | None | ||||||
| 6 months–2 years | 2 observational studies | None | Not serious | Not serious | Not serious | Low | 6198 |
| Over 2 years | None | ||||||
| 0–1 week | None | ||||||
| 1–12 weeks | 2 observational studies | None | Not serious | Not serious | Not serious | Low | 123 |
| 12 weeks–6 months | None | ||||||
| 6 months–2 years | 1 observational study | None | Not serious | Not serious | Not serious | Low | 44 |
| Over 2 years | None | ||||||
| 0–1 week | 1 observational study | None | Not serious | Not serious | Not serious | Low | 64 |
| 1–12 weeks | None | ||||||
| 12 weeks–6 months | 1 observational study | None | Not serious | Not serious | Not serious | Low | 862 |
| 6 months–2 years | None | ||||||
| Over 2 years | None | ||||||
| 0–1 week | None | ||||||
| 1–12 weeks | None | ||||||
| 12 weeks–6 months | None | ||||||
| 6 months–2 years | 1 observational study | None | Not serious | Not serious | Not serious | Low | 140 |
| Over 2 years | None | ||||||
| 0–1 week | None | ||||||
| 1–12 weeks | None | ||||||
| 12 weeks–6 months | None | ||||||
| 6 months–2 years | 1 observational study | None | Not serious | Serious | Not serious | Very low | 441 |
| Over 2 years | None | ||||||
WOMAC Western Ontario and McMaster University Osteoarthritis Index, VASVisual analogue scale, SF-36 Short-form health survey, BPI Brief pain index, HOOS Hip Dysfunction and Osteoarthritis Outcome Score
GRADE pain and function
| Certainty assessment | No. of patients | ||||||
|---|---|---|---|---|---|---|---|
| Outcome measure | Study design | Risk of Bias | Inconsistency | Indirectness | Imprecision | Quality | |
| WOMAC | |||||||
| 0–1 week | None | ||||||
| 1–12 weeks | None | ||||||
| 12 weeks–6 months | None | ||||||
| 6 months–2 years | 1 observational Study | None | Not serious | Not serious | Not serious | Low | 677 |
| Over 2 years | None | ||||||
WOMAC Western Ontario and McMaster University Osteoarthritis Index